Ninety One (UK)’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-1,451
Closed -$67K 358
2015
Q4
$67K Sell
1,451
-2,299,982
-100% -$103M ﹤0.01% 316
2015
Q3
$99.4M Sell
2,301,433
-356,622
-13% -$15M 0.62% 58
2015
Q2
$112M Buy
2,658,055
+146,359
+6% +$6.17M 0.64% 56
2015
Q1
$97.4M Buy
2,511,696
+169,980
+7% +$6.55M 0.57% 65
2014
Q4
$78.8M Buy
2,341,716
+47,630
+2% +$1.68M 0.48% 76
2014
Q3
$80.3M Buy
2,294,086
+85,100
+4% +$2.92M 0.47% 79
2014
Q2
$72.6M Buy
2,208,986
+1,169,500
+113% +$40M 0.42% 88
2014
Q1
$38.3M Buy
1,039,486
+3,600
+0.3% +$132K 0.26% 110
2013
Q4
$39.8M Buy
1,035,886
+82,300
+9% +$2.6M 0.28% 97
2013
Q3
$26.1M Buy
953,586
+296,706
+45% +$7.03M 0.19% 116
2013
Q2
$13.8M Buy
+656,880
New +$12.8M 0.11% 148

Other funds holding WX

Ninety One (UK)'s WX Position: Q1 2016 in Review

Ninety One (UK) sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2016, closing a stake of 1,451 shares — an estimated $67K sold.

Ninety One (UK) first reported a position in WX in Q2 2013 and held it in 11 quarters. The position peaked at $112M in Q2 2015. 1 fund tracked by Wall St. Rank holds WX as of Q1 2016.

  • Ninety One (UK) reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2016 after selling out during the quarter.
  • Ninety One (UK) sold 1,451 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2016, an estimated $67K.
  • Ninety One (UK) first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 11 quarters.
  • Ninety One (UK)'s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $112M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2016.

Based on Ninety One (UK)'s 13F filing for Q1 2016, filed 12 May 2016.